Breast Cancer Prevention Trials Using Retinoids

Abstract

Retinoids have been studied as chemopreventive agents in clinical trials. Given their ability to inhibit mammary carcinogenesis in preclinical models. Fenretinide has extensively been investigated because of its favorable toxicological profile in humans. In a phase III secondary prevention trial, fenretinide showed a trend to a reduction of second breast… (More)
DOI: 10.1023/A:1025779120649

4 Figures and Tables

Topics

  • Presentations referencing similar topics